Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030-4211, United States
Location status: Recruiting
Location contact
Hilary Touchett, PhD MSN BSN
PRINCIPAL_INVESTIGATOR
Jan A Lindsay, PhD
CONTACT
Suzette Stine, MBA BS
CONTACT
NCT Number: NCT06587607
This study involves delivering a mindfulness program that was developed for Veterans called VA Compassionate Awareness Learning Module (VA CALM) to Veterans with spinal cord injuries (SCI) to develop accommodations to make the VA CALM program more accessible for those with SCI. It will involve delivering the unmodified curriculum to a group of Veterans with SCI first to determine what areas need accommodations, working with a group of stakeholders to develop appropriate accommodations, and then delivering 1-2 modified modules via virtual reality to evaluate whether using virtual reality was feasible and acceptable for this program.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77030-4211, United States
Location status: Recruiting
Hilary Touchett, PhD MSN BSN
PRINCIPAL_INVESTIGATOR
Jan A Lindsay, PhD
CONTACT
Suzette Stine, MBA BS
CONTACT
The objectives of this study are to explore the feasibility and acceptability of a spinal cord injury (SCI) tailored, evidence-based mindfulness group known as VA Compassionate Awareness Learning Module (VA CALM) when delivered via virtual reality (VR) The project will first assess modification needs for SCI and then explore the feasibility and acceptability of delivering VA CALM-SCI over VR.
The long-term goals and significance of this study include studying the efficacy of VA CALM-SCI for the treatment of chronic pain and examining the comparative effectiveness between VR and video telehealth modalities to build evidence for the modified intervention. This work has the potential to improve care for Veterans with SCI who are at risk of being left out of innovative clinical advancements that improve quality of life and well-being, due to the complexity of their medical condition.
Aim 1: Conduct a formative evaluation of the VA CALM program to develop accommodations to improve program accessibility and acceptability for Veterans with SCI and chronic pain (VA CALM-SCI).
Aim 2: Explore the feasibility and acceptability of delivering VA CALM-SCI over a Virtual Reality platform for Veterans with SCI and chronic pain.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-Individuals unable to consent for research or medical care are ineligible to participate.
VA CALM is a 9 week mindfulness curriculum typically delivered at a once/week module pace in group settings during sessions that last approximately 60-90 minutes. Module topics include: Program Introduction, Why mindfulness, Perception, What Makes Something a Pleasant Experience?, Being Stuck, Getting Unstuck, Communication, Mindfulness in Daily Life, and Today is the First Dat of the Rest of Your Life.
Other names: VA CALM
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Minimum Score: 1 Maximum Score: 5 Score Interpretation: Items are aggregated and averaged. Higher scores indicate greater mindfulness.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Minimum Score: 0 Maximum Score: 10 Score Interpretation: Single item measure, higher scores indicate greater pain intensity.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Minimum Score: 1 Maximum Score: 6 Score Interpretation: Items are aggregated and averaged. Higher scores indicate greater mindfulness
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Minimum Score: 8 Maximum Score: 40 Score Interpretation: Scores are converted into a T-score which rescales the score into a standardized score with a mean of 50 and a standard deviation of 10. Higher scores indicate greater pain interference.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Minimum Score: 0 Maximum Score: 6 Score Interpretation: Generates scores for two domains: Activity Engagement and Pain Willingness. Scores for each item in a domain are aggregated. Higher scores indicate higher levels of acceptance.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Minimum Score: 0 Maximum Score: 52 Score Interpretation: Generates a total score PCS-T and three subscale scores: Rumination, Magnification, and Helplessness. Total score above 30 indicates clinically relevant level of catastrophizing.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Minimum Score: 4 Maximum Score: 20 Score interpretation: Measure is comprised of 4 quality of life domains: physical health, psychological health, social relationships, and environment. Items for each domain are aggregated, averaged, then scaled for final scoring. Higher scores indicate higher quality of life.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Minimum Score: 0 Maximum Score: 21 Score Interpretation: Higher scores indicate more severe anxiety. 0-4: minimal anxiety, 5-9: mild anxiety, 10-14: moderate anxiety, 15-21: severe anxiety.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Minimum Score: 0 Maximum Score: 27 Score Interpretation: Item scores are aggregated. Higher scores indicate greater depression severity. 0: no depression, 1-4: minimal depression, 5-9: mild depression, 10-14: moderate depression, 15-19: moderately severe depression, 20-27: severe depression.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Minimum Score: 1 Maximum Score: 10 Score Interpretation: Single item. Higher score indicates greater virtual presence.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Minimum Score:1 Maximum Score: 7 Scoring interpretation: Measures 3 domains: Acceptance (ownership), Control (agency), and Change (perceived change in the body scheme). Item scores are aggregated then averaged for each domain. Higher scores indicate greater embodiment.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Minimum Score: 0 Maximum Score: 100 Score interpretation: Items aggregated. Higher scores indicate greater usability.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Raw component Minimum Score: 1 Raw component Maximum Score: 5
Percentile Minimum Score: 0 Percentile Minimum Score: 100
Score interpretation: Two scores are generated and evaluated: Raw component score (1-5) which is aggregated and then averaged and percentile score (0-100). Higher scores indicate better user experience for both scales.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Minimum Score: 1 Maximum Score: 5 Score interpretation: Items aggregated then averaged. Higher scores indicate greater acceptability.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Minimum Score: 1 Maximum Score: 5 Score interpretation: Items aggregated then averaged. Higher scores indicate greater appropriateness.
Contact information is provided by the study sponsor or research team.
Felicia Skelton, MD MS
CONTACT
Hilary Touchett, PhD MSN BSN
CONTACT
VA Office of Research and Development
Fed
Exploring Virtual Reality Mindfulness Training for Veterans With SCI and Chronic Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07419646
Central Nervous System Diseases, Chronic Pain
View Trial DetailsNCT02459028
Central Nervous System Diseases, Chronic Pain
Nottwil, Canton of Lucerne, Switzerland
View Trial DetailsNCT05236933
Behavior, Central Nervous System Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT02262234
Central Nervous System Diseases, Chronic Pain
West Orange, New Jersey, United States
View Trial Details